LOCKED-IN SYNDROME DUE TO MULTIPLE BRAIN STEM INFARCTIONS AND FOCI OF DEMYELINATION AFTER RADIATION THERAPY OF PITUITARY ADENOMA WITH ACROMEGALY

Locked-in syndrome (LIS) is a rare neurological disorder, usually appears as a result of the pons cerebellar damage, mostly after the brain stroke. Locked-in syndrome is characterized by the paralysis of skeletal muscles (respiratory, facial, pharyngeal, lingual and muscles of the extremities). Patient is unable to speak and breath, facial expressions and voluntary movements are also impossible. Acromegaly is a disease that can be described by the increase of the growth hormone (GH) and Insulin-like growth factor (IGF-1) and develops in most cases due to the pituitary adenomas. Pituitary adenoma (PA) can be treated by neurosurgical techniques, pharmaceutical and radiation therapy (RT). We present a clinical case of 33-year-old woman with PA-caused acromegaly, that developed muscle weakness, nausea, vomit and respiratory disturbance in a 2 months after the radiation therapy. Subacute comatose state was developed in the patient. MRI of the brain revealed a multi-focal lesion of the media-basal regions on both sides, frontal corpus callosum and brain stem. Differential diagnosis included an acute demyelination (SD, PML), viral encephalitis and vasculitis. Treatment included methylprednisolone pulse therapy and plasmapheresis. The consciousness cleared up, but there was no spontaneous breathing, tetraplegia persisted. Autoimmune and infectious diseases was excluded. The homozygous mutation PAI-1-675 4G/4G was found. In this case, acromegaly induced endothelial dysfunction was the pathogenesis factor of multiple cerebral infarctions and demyelinating lesions, as well as RT and its proven pathological influence on the vascular wall and the fibrinolytic system. The revealed thrombophilia was also a factor of multiple cerebral infarctions. A Potential combination of pathogenic factors in the development of cerebral should be taken into account in predicting complications of RT.

acromegaly, radiation therapy, multiple brain stem infarctions, Locked-in syndrome

1. Krasil’nikova L. A., Tyutin L. A. Ultrasound diagno¬sis of angiopathy with anticancer therapy. Voprosy onkologii [Questions of Oncology], 2003, no 5, vol.49 pp. 595-6002.

2. Bauer G., Gerstenbrand F., Rumpl E. Varieties of the locked-in syndrome. J. Neurol. 1979;221(2):77-91.

3. Colao A, Ferone D, Marzullo P, Lombardi G (2004) System¬ic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev25:102-152. Doi:10.1210/er.2002-0022.

4. Molitch ME. Diagnosis and Treatment of Pituitary Ad-enomas A Review. JAMA. 2017;317(5):516-524.

5. Amanda J Walker, Jake Ruzevick, Ashkan A Malayeri et al. Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progres¬sion? Future Oncol. 2014 May; 10(7): 1277-1297.

6. Freeman JE, Johnston PG, Voke JM. Somnolence after prophylactic cranial irradiation in children with acute lympho¬blastic leukaemia. Br Med J. 1973;4(5891):523-525.

7. Sheline GE, Wara WM, Smith V Therapeutic irradi¬ation and brain injury. Int J Radiat Oncol Biol Phys. 1980; 6(9):1215-1228.

8. Glass JP, Hwang TL, Leavens ME, Libshitz HI. Cere¬bral radiation necrosis following treatment of extracranial malignancies. Cancer. 1984;54(9):1966-1972.

9. Leibel SA, Sheline GE. Tolerance of the Brain and Spinal Cord to Conventional Irradiation. Raven Press; NY, USA: 1991: 211-239.

10. McDonald LW, Hayes TL. The role of capillaries in the pathogenesis of delayed radionecrosis of brain. Am J Pathol. 1967;50(5):745-764.

11. Burger PC, Boyko OB. The pathology of central ner¬vous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, editors. Radiation Injury to the Nervous System. Raven; NY, USA: 1991: 191-208.

12. Kurita H, Kawahara N, Asai A, Ueki K, Shin M, Kirino T. Radiation-induced apoptosis of oligodendrocytes in the adult rat brain. Neurol Res. 2001;23(8):869-874.

13. Yoshii Y Pathological review of late cerebral radione-crosis. Brain Tumor Pathol. 2008;25(2):51-58.

14. Sawaya RE. The fibrinolytic enzymes in the biology. In: Sawaya RE, editor. Fibrinolysis and the Central Nervous System. Hanley & Belfus; PA, USA: 1990: 106-126.

15. Milic M, Rees JH. Acute demyelination following radiotherapy for glioma: a cautionary tale. Pract Neurol. 2017 Jan;17(1):35-38.

16. C. Sievers, P. G. Sämann, T. Dose, C. Dimopoulou et al. Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pitu¬itary. 2009 Sep; 12(3): 177-185.

17. Sartori MT, Wiman B, Vettore S, et al. 4G/5G poly-morphism of PAI-1 gene promoter and fibrino)lytic capacity in patients with deep vein thrombosis. Thromb Haemost. 1998 Dec;80(6):956-60.

18. Van Goor ML, Gómez García E, Leebeek F, et al. The plasminogen activator inhibitor (PAI-1) 4G/5G pro¬moter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. Thromb Haemost. 2005 Jan;93(1):92-6. Prog Brain Res. 2005;150:495-511.